Hoth Therapeutics Company Top Insiders

Hoth Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.8446) % which means that it has lost $0.8446 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5113) %, meaning that it created substantial loss on money invested by shareholders. Hoth Therapeutics' management efficiency ratios could be used to measure how well Hoth Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1. The current Return On Capital Employed is estimated to decrease to -1.13. As of now, Hoth Therapeutics' Net Tangible Assets are increasing as compared to previous years. The Hoth Therapeutics' current Debt To Assets is estimated to increase to 0.01, while Total Assets are projected to decrease to under 6.3 M. The Hoth Therapeutics' current Common Stock Shares Outstanding is estimated to increase to about 7.7 M, while Net Loss is forecasted to increase to (12.2 M). Hoth Therapeutics has a total of 15.51 Million outstanding shares. Hoth Therapeutics retains 3.57 (percent) of its outstanding shares held by insiders and 6.36 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Hoth Therapeutics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Hoth Therapeutics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Hoth Therapeutics Workforce Comparison

Hoth Therapeutics Insider Trading

Hoth Therapeutics Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Hoth Therapeutics often depends on how effective the management is. Hoth Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Hoth management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Hoth management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.